Diadexus, Inc. and Sonic Healthcare USA Sign National Agreement for PLAC(R) Activity Test

Diadexus, Inc. and Sonic Health care U.S.A Sign National Contract for PLAC(R) Activity Test

SOUTH SAN FRANCISCO, CA– (Marketwired)– 05/23/16– Diadexus, Inc. (OTCQB: DDXS), a diagnostics company establishing and commercializing products that aid in evaluating the prognosis of heart condition, today revealed it has signed an arrangement with Sonic Health care USA to launch the company’s PLAC ® Activity Test into Sonic’s nationwide network of labs. Sonic Health care USA is the fifth largest supplier of lab services in the United States and is part of Sonic Healthcare, the world’s 3rd biggest international laboratory company. The PLAC ® Test for Lp-PLA2 Activity is the only FDA-cleared test used in combination with medical assessment and patient risk evaluation as an aid in forecasting the danger of coronary cardiovascular disease (CHD) in clients with no prior history …
< a href=http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=AFEA4C1DA6D04370BB868BF1A975E4D4&url=http%3a%2f%2fmarkets.financialcontent.com%2fstocks%2fnews%2fread%3fGUID%3d32158237&c=4044576625192314408&mkt=en-gb target="_ blank

“> See all stories on this subject Interpace Diagnostics Presents New Medical Utility Data at Digestive Illness Week

SAN DIEGO, Might 23, 2016/ PRNewswire/– Interpace Diagnostics Corp. (IDXG), a company that offers scientifically helpful molecular diagnostic tests and pathology services … cancer danger assessment. PancraGEN is 90% precise, according to clinical researches …
See all stories on this subject

Scroll to Top